NASDAQ : VYNE

VYNE Therapeutics Inc.

$0.761 USD

-$0.01 (-0.85%)

Volume
1.01M
Average Volume
534.06K
Market Capitalization
$12.68M
P/E Ratio
-1.57
Dividend Yield
0.00%
Price Target
$5.75
Year High
$1.60
Year Low
$0.28
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$20.86
VYNE vs. The Competition
Properties VYNE AIM BCLI ENSC
Market Cap $12.68M $874.71K $9.93M $2.62M
Shares Outstanding $16.66M $3.4M $11.03M $9.28M
P/E Ratio -1.57 -0.14 -0.96 -0.08
EPS -0.5 -3.05 -0.87 -1.72
Day Low 0.7412 0.2525 0.88 0.2717
Day High 0.78 0.2686 0.95 0.2889
Year Low 0.281 0.21 0.46 0.23
Year High 1.595 19.73812 1.69 2.75
Average Price 50 0.66952 0.3782 0.8562 0.29062
Average Price 200 0.5507 1.05008 0.72335 0.92809
Volume 1.01M 462.34K 9043 195.73K
Average Volume - - - -
VYNE Top Competitors
Symbol Name Last Change %Chg Volume
AIM AIM ImmunoTech Inc. $0.257 -0.016 -5.86% 462.34K
BCLI Brainstorm Cell Therapeutics Inc. $0.9 -0.0425 -4.51% 9043
ENSC Ensysce Biosciences, Inc. $0.2828 0.0054 1.95% 195.73K